Money India

Financial Blog about stocks, share market, realty, investments, loans, credit cards
  • Home
  • Money Blog
  • G20 move exceeds expectations, says George Soros
Switcher
Home > News > Ranbaxy Labs in poor health

Ranbaxy Labs in poor health

June 26th, 2009

Ranbaxy Laboratories touched an intraday high of Rs 269 and an intraday low of Rs 250. At 1:46 pm, the share was quoting at Rs 257.20, down Rs 9.65, or 3.62%.

US advocacy group is raising objections to Walmart importing drugs from Ranbaxy, quoting The Financial Express, reports CNBC-TV18.

It was trading with volumes of 331,917 shares. Yesterday the share closed down 2.36% or Rs 6.45 at Rs 266.85.

Source

rupees News

Comments are closed.
Voltas has target of Rs 139: H Thukral Network 18 Media puts on a good show
RSS feed
  • Google
  • Youdao
  • Xian Guo
  • Zhua Xia
  • My Yahoo!
  • newsgator
  • Bloglines
  • iNezha

Recent Posts

  • Consumers worried about poor monsoon, food-led inflation
  • Limited upside in Great Offshore: N Shah
  • Nifty lacklustre; pharma, oil mkting, metals, realty up
  • Block deal strengthens Shriram Transport Finance
  • PSU bank employees on 2-day nationwide strike for pay hike
  • No plans of superseding Maytas Infra board: Govt
  • L&T seeks regulatory approval to sell Satyam stake
  • 3 lakh shareholders file Rs 4987cr suit against Satyam in SC
  • Weakness in China causing unease in global mkts: Udayan
  • See Sensex at 17500, Nifty at 5000 soon: Daryl Guppy

Categories

  • Business
  • Insurance
  • Investing
  • Money
  • Mutual Funds
  • News
  • Real Estate
  • Stocks

Archives

  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • January 2007
  • December 2006
  • November 2006
  • October 2006

Meta

  • Log in
Top WordPress
Copyright © 2006-2009 Money India
Proudly Hosted by Reliable Network from Hostgator